Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study

Citation
Ag. Thrift et al., Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study, BR MED J, 318(7186), 1999, pp. 759-764
Citations number
31
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
BRITISH MEDICAL JOURNAL
ISSN journal
09598138 → ACNP
Volume
318
Issue
7186
Year of publication
1999
Pages
759 - 764
Database
ISI
SICI code
0959-8138(19990320)318:7186<759:ROPIHA>2.0.ZU;2-Q
Abstract
Objective To examine the association between use of aspirin or other non-st eroidal anti-inflammatory drugs and intracerebral haemorrhage. Design Case-control study. Setting 13 major city hospitals in the Melbourne and metropolitan area. Subjects 331 consecutive cases of stroke verified by computed tomography or postmortem examination, and 331 age (+/- 5 years) and sex matched controls who were community based neighbours. Interventions (Questionnaire administered to all subjects either directly o r by proxy with the next of kin. Drug use was validated by reviewing prescr ibing records held by the participants' doctors. Main outcome measures Previous use of aspirin or other non-steroidal anti-i nflammatory drugs. Results Univariate analysis showed no increased risk of intracerebral haemo rrhage with low dose aspirin use in the preceding 2 weeks. Using multiple l ogistic regression to control for possible confounding factors, the odds ra tio associated with die use of aspirin was 1.00 (95% confidence interval 0. 60 to 1.66, P = 0.998) and the odds ratio associated with the use of other non-steroidal anti-inflammatory drugs was 0.85 (0.45 to 1.61, P = 0.611) co mpared with respective non-users in the preceding fortnight. Moderate to hi gh doses of aspirin (> 1225 mg/week spread over at least three doses) yield ed an odds ratio of 3.05 (1.02 to 9.14, P= 0.047). There was no evidence of an increased risk among subgroups defined by age, sex, Mood pressure statu s, alcohol intake, smoking, and the presence or absence of previous cardiov ascular disease. Conclusions No increase in risk of intracerebral haemorrhage was found amon g aspirin users overall or among those who took low doses of the drug or ot her non-steroidal anti-inflammatory drugs. These data provide evidence that doses of aspirin usually used for prophylaxis against vascular disease pro duce no substantial increase in risk of intracerebral haemorrhage.